SCHEDULE 13G/A: Vanguard Group Discloses 10% Passive Stake in Crinetics Pharmaceuticals
Beneficial Ownership Filing
The Vanguard Group has filed an amended Schedule 13G, revealing a 10% beneficial ownership stake in Crinetics Pharmaceuticals Inc. as of March 31, 2025.
Summary
- The Vanguard Group, an investment adviser based in Pennsylvania, filed an Amendment No. 4 to its Schedule 13G.
- The filing discloses The Vanguard Group's beneficial ownership in Crinetics Pharmaceuticals Inc. (CUSIP: 22663K107).
- As of March 31, 2025, Vanguard beneficially owns an aggregate of 9,311,600 shares of Crinetics Pharmaceuticals Inc. Common Stock.
- This ownership represents 10% of the class of securities.
- Vanguard holds sole voting power over 0 shares, shared voting power over 107,465 shares, sole dispositive power over 9,092,816 shares, and shared dispositive power over 218,784 shares.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or outlook.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The disclosure of a significant 10% passive stake by a major institutional investor like Vanguard can be viewed positively, potentially indicating institutional confidence in Crinetics Pharmaceuticals Inc. and contributing to market liquidity.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires the filing of this statement (beneficial ownership calculation date). |
| 04/07/2025 | Date the Schedule 13G Amendment No. 4 was signed and filed. |
Keywords
Crinetics Pharmaceuticals, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.